Medicare Enrolled
Dr. Scott Cooper, M.D.
Neurology · Cumming, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cooper from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cooper?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cooper
Dr. Scott Cooper is a neurology specialist in Cumming, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cooper performed 1,718 Medicare services across 1,259 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cooper received a total of $300,998 from 87 pharmaceutical and/or device companies across 1586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cooper is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in GA
$300,998 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,718
Medicare services
Top 21% in GA for neurology
1,259
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
447 | $48 | $188 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
377 | $125 | $503 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
239 | $98 | $387 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
158 | $181 | $720 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
138 | $11 | $47 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
113 | $1 | $12 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
65 | $0 | $5 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
57 | $219 | $817 |
| New patient office visit, complex (60-74 min) | 53 | $128 | $668 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
38 | $42 | $167 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
20 | $218 | $815 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
13 | $41 | $158 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$300,998
Total received (2018-2024)
Avg $43,000/year across 7 years
Top 3% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
1,586
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$284,698 (94.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,321 (5.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$979 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$52,015
2023
$35,666
2022
$34,779
2021
$40,742
2020
$52,684
2019
$37,889
2018
$47,223
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$29,948
Teva Pharmaceuticals USA, Inc.
$14,537
UCB, Inc.
$4,894
PFIZER INC.
$300
Otsuka America Pharmaceutical, Inc.
$267
ARGENX US, INC.
$214
SK Life Science, Inc.
$196
Alexion Pharmaceuticals, Inc.
$161
Novartis Pharmaceuticals Corporation
$157
Lilly USA, LLC
$143
MDD US Operations, LLC
$135
Neurocrine Biosciences, Inc.
$126
Lundbeck LLC
$110
Amneal Pharmaceuticals LLC
$107
Biogen, Inc.
$94
Celgene Corporation
$87
Kyowa Kirin, Inc.
$78
Sumitomo Pharma America, Inc.
$74
Acorda Therapeutics, Inc
$49
ANI Pharmaceuticals, Inc.
$49
Vanda Pharmaceuticals Inc.
$47
JAZZ PHARMACEUTICALS INC.
$46
ACADIA Pharmaceuticals Inc
$33
CATALYST PHARMACEUTICALS, INC.
$30
Genentech USA, Inc.
$24
Azurity Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$24
Eisai Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$22
Aucta Pharmaceuticals, Inc.
$18
Top 3 companies account for 94.9% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$111,396
ABBVIE INC.
$42,760
AbbVie Inc.
$37,390
Allergan, Inc.
$34,739
UCB, Inc.
$25,768
Avanir Pharmaceuticals, Inc.
$11,553
Corium, LLC
$7,558
Lundbeck LLC
$7,406
Adamas Pharmaceuticals, Inc.
$3,870
US WorldMeds, LLC
$2,286
Biogen, Inc.
$1,506
Allergan Inc.
$1,145
Novartis Pharmaceuticals Corporation
$932
Sunovion Pharmaceuticals Inc.
$824
Alexion Pharmaceuticals, Inc.
$807
PFIZER INC.
$712
Amgen Inc.
$681
SK Life Science, Inc.
$672
Lilly USA, LLC
$660
Amneal Pharmaceuticals LLC
$585
Eisai Inc.
$529
GENZYME CORPORATION
$525
Neurocrine Biosciences, Inc.
$491
Otsuka America Pharmaceutical, Inc.
$463
Supernus Pharmaceuticals, Inc.
$440
Kyowa Kirin, Inc.
$402
Neurelis, Inc.
$378
EISAI INC.
$344
ARGENX US, INC.
$334
Acorda Therapeutics, Inc
$318
MDD US Operations, LLC
$260
Biohaven Pharmaceutical Holding Company Ltd.
$216
Sumitomo Pharma America, Inc.
$177
Alnylam Pharmaceuticals Inc.
$151
CSL Behring
$149
Genentech USA, Inc.
$148
JAZZ PHARMACEUTICALS INC.
$131
AbbVie, Inc.
$125
Celgene Corporation
$118
Zyla Life Sciences, Inc.
$110
ACADIA Pharmaceuticals Inc
$102
Grifols USA, LLC
$98
Greenwich Biosciences, Inc.
$95
Biohaven Pharmaceuticals, Inc.
$94
Daiichi Sankyo Inc.
$88
Currax Pharmaceuticals LLC
$75
Vanda Pharmaceuticals Inc.
$73
ANI Pharmaceuticals, Inc.
$73
ARBOR PHARMACEUTICALS, INC.
$64
Mallinckrodt LLC
$58
Aprecia Pharmaceuticals, LLC
$56
Janssen Pharmaceuticals, Inc
$55
LivaNova USA, Inc.
$55
Impax Laboratories, Inc.
$48
AQUESTIVE THERAPEUTICS, INC.
$46
Mallinckrodt Enterprises LLC
$46
Arbor Pharmaceuticals, Inc.
$45
EMD Serono, Inc.
$43
Azurity Pharmaceuticals, Inc.
$42
Avion Pharmaceuticals
$39
IMPEL PHARMACEUTICALS INC.
$38
SANOFI-AVENTIS U.S. LLC
$37
Astellas Pharma US Inc
$37
Vertical Pharmaceuticals, LLC
$35
E.R. Squibb & Sons, L.L.C.
$33
GE Healthcare
$31
CATALYST PHARMACEUTICALS, INC.
$30
Catalyst Pharmaceuticals, Inc.
$29
Abbott Laboratories
$28
TerSera Therapeutics LLC
$28
Endo Pharmaceuticals Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$22
PORTOLA PHARMACEUTICALS, INC.
$22
PORTOLA PHARMACEUTICALS, LLC
$22
Mallinckrodt Hospital Products Inc.
$20
Mylan Pharmaceuticals Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Chiesi USA, Inc.
$19
Zyla Life Sciences
$19
Almatica Pharma LLC
$18
Aucta Pharmaceuticals, Inc.
$18
Upsher-Smith Laboratories LLC
$18
AstraZeneca Pharmaceuticals LP
$17
Harmony Biosciences LLC
$16
Medtronic, Inc.
$15
OWP Pharmaceuticals, Inc.
$14
Collegium Pharmaceutical, Inc.
$13
Top 3 companies account for 63.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · BRILINTA · Briviact · CHANTIX · CLEVIPREX · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cenobamate · DUOPA · Dhivy · Duopa · ELIQUIS · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · ERGOMAR · Epidiolex · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gocovri · HETLIOZ · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INJECTAFER · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LINQ II · LINZESS · LUMIZYME · LYRICA · LYVISPAH · Leqembi · MYOBLOC · MYRBETRIQ · Mavenclad · Motpoly XR · NAMZARIC · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · POMPE - DISEASE · PONVORY · PRADAXA · PRIALT · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · REXULTI · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · Spritam · Subvenite · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · Utibron · VALTOCO · VESICARE · VIBERZI · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XADAGO · Xadago · ZAVZPRET · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in GA.
Geographic Context
Neurologists within 10 mi
88
Per 100K population
33.8
County median income
$138,000
Nearest hospital
NORTHSIDE HOSPITAL FORSYTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cooper is a clinical cardiology specialist, with above-average Medicare volume (top 21% in GA), with speaking/promotional industry engagement in the top 3% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cooper experienced with limited needle emg of arm or leg muscles?
Based on Medicare claims data, Dr. Cooper performed 447 limited needle emg of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cooper receive payments from pharmaceutical companies?
Yes. Dr. Cooper received a total of $300,998 from 87 companies across 1,586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cooper's costs compare to other neurologists in Cumming?
Dr. Cooper's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cooper) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Cumming
Browse neurologists in Cumming ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology